QuickView for CHRM5;jsessionid=698B8D14B90AC3364F16A7908A099C62 (gene)

1. Recessive CHRM5 variant as a potential cause of neurogenic bladder.
2. Allosteric modulation of a chemogenetically modified G protein-coupled receptor.
3. Muscarinic receptor trafficking.
4. Activation and dynamic network of the M2 muscarinic receptor.
5. The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies.

There were no clinical trials for CHRM5;jsessionid=698B8D14B90AC3364F16A7908A099C62